[1] LARROCHE C.Hemophagocytic lymphohistiocytosis in adults:diagnosis and treatment[J].Joint Bone Spine,2012,79(4):356-361.
[2] WEISS E S,GIRARD-GUYONVARC'H C,HOLZINGER D,et al.Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome[J].Blood,2018,131(13):1442-1455.
[3] DALAL B I,VAKIL A P,KHARE N S,et al.Abnormalities of the lymphocyte subsets and their immunophenotype,and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis[J].Ann Hematol,2015,94(7):1111-1117.
[4] CETICA V,SIENI E,PENDE D,et al.Genetic predisposition to hemophagocytic lymphohistiocytosis:report on 500 patients from the Italian registry[J].J Allergy Clin Immunol,2016,137(1):188-196.
[5] ZHANG K,CHANDRAKASAN S,CHAPMAN H,et al.Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis[J].Blood,2014,124(8):1331-1334.
[6] KAUFMAN K M,LINGHU B,SZUSTAKOWSKI J D,et al.Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis[J].Arthritis Rheumatol,2014,66(12):3486-3495.
[7] CHOI J E,KWAK Y,HUH J W,et al.Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide[J].Korean J Pediatr,2018,61:167-173.
[8] MARUOKA H,INOUE D,TAKIUCHI Y,et al.IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome[J].Ann Hematol,2014,93(3):393-401.
[9] CHEN J,WANG X,HE P,et al.Viral etiology,clinical and laboratory features of adult hemophagocytic lymphohistiocytosis[J].J Med Virol,2016,88(3):541-549.
[10] LI J,WANG Q,ZHENG W,et al.Hemophagocytic lymphohistiocytosis:clinical analysis of 103 adult patients[J].Medicine (Baltimore),2014,93(2):100-105.
[11] TAKEUCHI O,AKIRA S.Pattern recognition receptors and inflammation[J].Cell,2010,140(3):805-811.
[12] FILIPOVICH A,MCCLAIN K,GROM A.Histiocytic disorders:recent insights into pathophysiology and practical guidelines[J].Biol Blood Marrow Transplant,2010,16(1):S82-89.
[13] PUT K,AVAU A,BRISSE E,et al.Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis:tipping the balance between interleukin-18 and interferon-γ[J].Rheumatology (Oxford),2015,54(8):1507-1517.
[14] WANG L L,HU Y X,CHEN W F,et al.Significance of soluble interleukin-2 receptor and NK cell activity in patients with hemophagocytic lymphohistiocytosis[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2012,20(1):401-409.
[15] ROUSSELIN A,ALAVI Z,et al.Hemophagocytic syndrome in pregnancy:case report,diagnosis,treatment,and prognosis[J].Clin Case Rep.2017,5(11):1756-1764.
[16] YILDIZ H,VANDERCAM B,et al.Hepatitis during pregnancy:a case of hemophagocytic lymphohistiocytosis[J].Clin Res Hepatol Gastroenterol.2018,Jun;42(3):e49-e55.
[17] RAMOS-CASALS M,BRITO-ZERON P,LOPEZ-GUILLERMO A,et al.Adult haemophagocytic syndrome[J].Lancet,2014,383:1503.
[18] OTROCK Z K,EBY C S.Clinical characteristics,prognostic factors,and outcomes of adult patients with hemophagocytic lymphohistiocytosis[J].Am J Hematol,2015,90(3):220-224.
[19] JOVANOVIC A,KUZMANOVIC M,KRAVLJANAC R,et al.Central nervous system involvement in hemophagocytic lymphohistiocytosis:a single-center experience[J].Pediatr Neurol,2014,50(2):233-237.
[20] RUBIN T S,ZHANG K,GIFFORD C,et al.Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH[J].Blood,2017,129(22):2993-2999.
[21] MELLOR-HEINEKE S,VILLANUEVA J,JORDAN M B,et al.Elevated granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis[J].Front Immunol,2013,29(4):72-80.
[22] ROSADO F G,RINKER E B,PLUMMER W D,et al.The diagnosis of adult-onset haemophagocytic lymphohistiocytosis:lessons learned from a review of 29 cases of bone marrow haemophagocytosis in two large academic institutions[J].J Clin Pathol,2016,69(9):805-809.
[23] RIVIōRE S,GALICIER L,COPPO P,et al.Reactive hemophagocytic syndrome in adults:a retrospective analysis of 162 patients[J].Am J Med,2014,127(11):1118-1125.
[24] LEHMBERG K,MCCLAIN K L,JANKA G E,et al.Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2014,61(11):2101-2103.
[25] HEJBLUM G,LAMBOTTE O,GALICIER L,et al.A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients[J].PLoS One,2014,9(4):e94024.
[26] ALLEN C E,YU X,KOZINETZ C A,McClain KL.Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2008,50(6):1227-1235.
[27] GARS E,PURINGTON N,SCOTT G,et al.Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis[J].Haematologica,2018,103(10):1635-1641.
[28] MACHACZKA M,NAHI H,KARBACH H,et al.Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation[J].Med Oncol,2012,29(2):1231-1236.
[29] FU L,WANG J,WEI N,et al.Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis:a single center analysis[J].Int J Hematol,2016,104(4):628-637.
[30] BERGSTEN E,HORNE A,ARICÓ M,et al.Confirmed efficacy of etoposide and dexamethasone in HLH treatment:long-term results of the cooperative HLH-2004 study[J].Blood,2017,130(25):2728-2738.
[31] JORDAN M B,ALLEN C E,WEITZMAN S,et al.How I treat hemophagocytic lymphohistiocytosis[J].Blood,2011,118(1):4041-4111.
[32] TAMAMYAN G N,KANTARJIAN H M,NING J,et al.Malignancy-associated hemophagocytic lymphohistiocytosis in adults:Relation to hemophagocytosis,characteristics,and outcomes[J].Cancer,2016,122(18):2857-2866.
[33] MARSH R A,JORDAN M B,FILIPOVICH A H.Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis:an important step forward[J].Br J Haematol,2011,154(5):556-563.
[34] MARSH R A,JORDAN M B,TALANO J A,et al.Salvage therapy for refractory hemophagocytic lymphohistiocytosis:A review of the published experience[J].Pediatr Blood Cancer,2017,64(4):1-7.
[35] ARCA M,FARDET L,GALICIER L,et al.Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome:impact of triggering disease and early treatment with etoposide[J].Br J Haematol,2015,168(1):63-71.
[36] PARIKH S A,KAPOOR P,LETENDRE L,et al.Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis[J].Mayo Clin Proc,2014,89(4):484-492.
[37] RIVIōRE S,GALICIER L,COPPO P,et al.Reactive hemophagocytic syndrome in adults:a retrospective analysis of 162 patients[J].Am J Med,2014,127(11):1118-1125.
[38] SCHRAM A M,MULLALLY A,FOGERTY A E,et al.Hemophagocytic lymphohistiocytosis:the partners healthcare experience over the past 8 years[J].Blood,2014,124(3):4104-4109. |